Spain

Spain

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

20-80 year olds
Download
Value (%) Year Type Source
0.22 (0.10 - 0.34) 2018 Survey/reported Ministerio de Sanidad, Servicios Sociales e Igualidad, 2020
National
Download
Value (%) Year Type Source
0 (0 - 1) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.4 (0.80 - 2.20) 2002 Survey/reported Salleras L et al, 2007
0.7 (0.50 - 1) 2009 Survey/reported Pedraza-Flechas et al, 2014
0.8 (0.60 - 1.10) 2016 Modelled ECDC
0.57 (0.44 - 0.72) 2015 Modelled WHO
0.6 (0.40 - 0.90) 2016 Modelled Razavi-Shearer et al, 2018
0.34 (0.32 - 0.37) 2013 Modelled Schweitzer et al, 2015
0.75 (0.67 - 0.83) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.83 (0.74 - 0.91) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.75 - 0.92) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.77 - 0.95) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.79 - 0.99) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.80 - 0.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.81 - 1) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.83 - 1.02) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.84 - 1.03) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.84 - 1.04) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.85 - 1.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.87 - 1.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.88 - 1.09) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.90 - 1.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.90 - 1.12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.91 - 1.12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.92 - 1.13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.93 - 1.15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.94 - 1.16) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.94 - 1.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.95 - 1.18) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.96 - 1.19) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.98 - 1.20) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.99 - 1.22) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.99 - 1.23) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (1 - 1.24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.13 (1.01 - 1.24) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (1.03 - 1.26) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (1.04 - 1.29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (1.05 - 1.30) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.73 - 0.91) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.19 (0.12 - 0.27) 2015 Modelled WHO
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.05 (0.04 - 0.07) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.10 - 0.20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.11 - 0.22) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.12 - 0.22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.12 - 0.23) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.13 - 0.23) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.13 - 0.23) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.16 - 0.28) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.22 - 0.38) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.29 - 0.52) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.39 - 0.69) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.48 - 0.88) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.11 - 0.15) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.50) 2009 Survey/reported Salleras L et al, 2009
People who inject drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported ECDC
10.5 2015 Survey/reported EMCDDA
11 2014 Survey/reported EMCDDA
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
9.4 2016 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.55 2017 Survey/reported ECDC Monitoring Report
Prisoners
Download
Value (%) Year Type Source
2.6 (0.80 - 4.50) 2008 Survey/reported Garcia-Guerrero J et al, 2010
2.6 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
287,000 (208,000 - 401,000) 2016 Modelled Razavi-Shearer et al, 2018
345,692 (307,911 - 382,208) 2019 Modelled IHME, GBD 2019 (accessed 2020)
356,319 (316,421 - 394,249) 2019 Modelled IHME, GBD 2019 (accessed 2022)
360,495 (322,840 - 395,683) 2018 Modelled IHME, GBD 2019 (accessed 2022)
365,569 (326,813 - 403,248) 2017 Modelled IHME, GBD 2019 (accessed 2022)
378,499 (337,840 - 416,622) 2016 Modelled IHME, GBD 2019 (accessed 2022)
390,885 (349,254 - 437,646) 2015 Modelled IHME, GBD 2019 (accessed 2022)
395,676 (354,301 - 438,180) 2014 Modelled IHME, GBD 2019 (accessed 2022)
402,192 (362,256 - 442,726) 2013 Modelled IHME, GBD 2019 (accessed 2022)
408,779 (367,309 - 451,377) 2012 Modelled IHME, GBD 2019 (accessed 2022)
413,764 (371,914 - 455,851) 2011 Modelled IHME, GBD 2019 (accessed 2022)
415,390 (372,502 - 461,605) 2010 Modelled IHME, GBD 2019 (accessed 2022)
415,988 (375,152 - 460,716) 2009 Modelled IHME, GBD 2019 (accessed 2022)
417,970 (377,456 - 461,954) 2008 Modelled IHME, GBD 2019 (accessed 2022)
419,722 (378,356 - 463,600) 2007 Modelled IHME, GBD 2019 (accessed 2022)
420,054 (377,991 - 466,341) 2006 Modelled IHME, GBD 2019 (accessed 2022)
417,253 (374,002 - 464,244) 2005 Modelled IHME, GBD 2019 (accessed 2022)
413,592 (371,789 - 458,542) 2004 Modelled IHME, GBD 2019 (accessed 2022)
411,928 (370,231 - 455,172) 2003 Modelled IHME, GBD 2019 (accessed 2022)
410,847 (367,915 - 452,545) 2002 Modelled IHME, GBD 2019 (accessed 2022)
409,464 (365,282 - 452,518) 2001 Modelled IHME, GBD 2019 (accessed 2022)
406,932 (361,989 - 450,925) 2000 Modelled IHME, GBD 2019 (accessed 2022)
405,024 (361,587 - 447,563) 1999 Modelled IHME, GBD 2019 (accessed 2022)
405,425 (362,903 - 447,601) 1998 Modelled IHME, GBD 2019 (accessed 2022)
406,896 (363,378 - 448,796) 1997 Modelled IHME, GBD 2019 (accessed 2022)
408,463 (364,830 - 450,998) 1996 Modelled IHME, GBD 2019 (accessed 2022)
409,084 (366,627 - 452,582) 1995 Modelled IHME, GBD 2019 (accessed 2022)
409,707 (367,241 - 453,662) 1994 Modelled IHME, GBD 2019 (accessed 2022)
411,860 (371,441 - 455,146) 1993 Modelled IHME, GBD 2019 (accessed 2022)
415,121 (374,501 - 460,555) 1992 Modelled IHME, GBD 2019 (accessed 2022)
419,042 (376,891 - 466,055) 1991 Modelled IHME, GBD 2019 (accessed 2022)
423,258 (379,777 - 472,362) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
346 2019 Survey/reported European Centre for Disease Prevention and Control, 2021

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.07 (1.59 - 2.63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.81 (2.99 - 4.84) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.79 (3.01 - 4.74) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (2.95 - 4.60) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.94 - 4.54) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.64 (2.92 - 4.50) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.92 - 4.51) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.92 - 4.49) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (2.87 - 4.44) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.47 (2.78 - 4.34) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (2.85 - 4.46) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (2.85 - 4.44) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.33 (2.67 - 4.16) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.09 (2.47 - 3.86) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.24 - 3.51) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.83 - 2.87) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (2 - 3.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.87 - 2.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.26 (1.79 - 2.81) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.2 (1.75 - 2.74) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.71 - 2.70) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.68 - 2.64) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.66 - 2.63) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.64 - 2.61) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.59 - 2.55) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.57 - 2.55) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.04 (1.58 - 2.59) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.56 - 2.60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.58 - 2.62) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.59 - 2.62) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.59 - 2.63) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,610 2016 Modelled WHO
1,479 (1,161 - 1,877) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,474 (1,169 - 1,843) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,449 (1,150 - 1,790) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,426 (1,145 - 1,762) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,435 (1,148 - 1,772) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,428 (1,149 - 1,772) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,434 (1,154 - 1,775) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,416 (1,139 - 1,762) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,427 (1,142 - 1,784) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,439 (1,151 - 1,792) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,415 (1,134 - 1,771) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,299 (1,036 - 1,621) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,379 (1,103 - 1,721) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,198 (957 - 1,498) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,091 (867 - 1,364) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,029 (819 - 1,285) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,026 (812 - 1,277) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,043 (827 - 1,307) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,016 (805 - 1,265) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,005 (797 - 1,257) 2009 Modelled IHME, GBD 2019 (accessed 2022)
988 (781 - 1,241) 2011 Modelled IHME, GBD 2019 (accessed 2022)
993 (787 - 1,242) 2010 Modelled IHME, GBD 2019 (accessed 2022)
955 (747 - 1,201) 2013 Modelled IHME, GBD 2019 (accessed 2022)
977 (772 - 1,229) 2012 Modelled IHME, GBD 2019 (accessed 2022)
945 (734 - 1,198) 2014 Modelled IHME, GBD 2019 (accessed 2022)
953 (738 - 1,208) 2015 Modelled IHME, GBD 2019 (accessed 2022)
945 (728 - 1,208) 2016 Modelled IHME, GBD 2019 (accessed 2022)
950 (732 - 1,217) 2017 Modelled IHME, GBD 2019 (accessed 2022)
951 (733 - 1,210) 2018 Modelled IHME, GBD 2019 (accessed 2022)
954 (732 - 1,212) 2019 Modelled IHME, GBD 2019 (accessed 2022)
954 (732 - 1,212) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
7 (5 - 10) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 11) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (6 - 14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2001 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 15) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 17) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 17) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 16) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2019 Survey/reported WHO/UNICEF
98 2020 Survey/reported WHO/UNICEF
92 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

20-80 year olds
Download
Value (%) Year Type Source
0.17 (0.08 - 0.28) 2018 Survey/reported Ministerio de Sanidad, Servicios Sociales e Igualidad, 2020
National
Download
Value (%) Year Type Source
0.8 (0.30 - 1.20) 2015 Modelled Blach et al, 2017
1.05 (0.85 - 1.27) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.86 - 1.27) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.85 - 1.27) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.85 - 1.25) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.83 - 1.25) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.84 - 1.25) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.84 - 1.25) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.84 - 1.26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.27) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.84 - 1.26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.83 - 1.22) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.80 - 1.15) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.76 - 1.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.72 - 0.98) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.71 - 0.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.72 - 0.97) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.75 - 1.01) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.79 - 1.05) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.82 - 1.10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.83 - 1.14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.85 - 1.17) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.87 - 1.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.89 - 1.24) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.90 - 1.27) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.90 - 1.29) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.90 - 1.28) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.89 - 1.27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.89 - 1.27) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.88 - 1.26) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.87 - 1.25) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.79 - 1.18) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
66.5 2015 Survey/reported EMCDDA; Ministry of Health
66.6 2014 Survey/reported EMCDDA; Ministry of Health
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.26 (0.14 - 0.42) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.1 (0.30 - 2.80) 2003 Survey/reported Lopez-Izquierdo R et al, 2007
1.7 (0.40 - 2.60) 2014 Modelled Gower et al, 2014
1.5 2019 Modelled Jin et al. 2017
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.2 (0.10 - 0.30) 2012 Survey/reported Seisdedos T et al, 2011
People who inject drugs (PWID)
Download
Value (%) Year Type Source
71 (69.50 - 72.50) 2012 Modelled Degenhardt L et al, 2017
64.4 2016 Survey/reported ECDC
64 2014 Survey/reported European Monitoring Centre for Drugs and Drug Addiction, 2019
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
64.4 2016 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2 2017 Survey/reported ECDC
Prisoners
Download
Value (%) Year Type Source
20.3 (18.90 - 21.70) 2009 Modelled ECDC
38.9 2010 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
386,000 (159,000 - 557,000) 2015 Modelled Blach et al, 2017
376,871 (315,690 - 452,253) 1990 Modelled IHME, GBD 2019 (accessed 2022)
382,805 (320,593 - 458,974) 1991 Modelled IHME, GBD 2019 (accessed 2022)
387,430 (324,864 - 464,748) 1992 Modelled IHME, GBD 2019 (accessed 2022)
391,247 (327,025 - 464,475) 1993 Modelled IHME, GBD 2019 (accessed 2022)
394,486 (329,609 - 467,692) 1994 Modelled IHME, GBD 2019 (accessed 2022)
397,125 (332,276 - 476,124) 1995 Modelled IHME, GBD 2019 (accessed 2022)
397,302 (332,994 - 469,980) 1996 Modelled IHME, GBD 2019 (accessed 2022)
393,099 (331,125 - 463,539) 1997 Modelled IHME, GBD 2019 (accessed 2022)
386,756 (327,278 - 452,282) 1998 Modelled IHME, GBD 2019 (accessed 2022)
380,263 (324,106 - 442,750) 1999 Modelled IHME, GBD 2019 (accessed 2022)
375,810 (320,249 - 437,285) 2000 Modelled IHME, GBD 2019 (accessed 2022)
370,528 (318,039 - 428,716) 2001 Modelled IHME, GBD 2019 (accessed 2022)
360,819 (310,605 - 417,890) 2002 Modelled IHME, GBD 2019 (accessed 2022)
350,361 (301,755 - 404,137) 2003 Modelled IHME, GBD 2019 (accessed 2022)
342,948 (293,686 - 397,771) 2004 Modelled IHME, GBD 2019 (accessed 2022)
342,732 (293,284 - 398,436) 2005 Modelled IHME, GBD 2019 (accessed 2022)
357,315 (302,965 - 416,039) 2006 Modelled IHME, GBD 2019 (accessed 2022)
385,152 (323,683 - 452,118) 2007 Modelled IHME, GBD 2019 (accessed 2022)
418,079 (347,944 - 498,463) 2008 Modelled IHME, GBD 2019 (accessed 2022)
446,623 (365,595 - 537,847) 2009 Modelled IHME, GBD 2019 (accessed 2022)
460,505 (372,214 - 560,572) 2010 Modelled IHME, GBD 2019 (accessed 2022)
461,936 (375,165 - 562,284) 2011 Modelled IHME, GBD 2019 (accessed 2022)
459,651 (374,571 - 559,404) 2012 Modelled IHME, GBD 2019 (accessed 2022)
455,777 (372,444 - 554,933) 2013 Modelled IHME, GBD 2019 (accessed 2022)
452,068 (370,684 - 554,747) 2014 Modelled IHME, GBD 2019 (accessed 2022)
449,888 (367,949 - 554,130) 2015 Modelled IHME, GBD 2019 (accessed 2022)
451,277 (370,889 - 551,066) 2016 Modelled IHME, GBD 2019 (accessed 2022)
453,773 (371,353 - 554,394) 2017 Modelled IHME, GBD 2019 (accessed 2022)
455,320 (373,456 - 553,519) 2018 Modelled IHME, GBD 2019 (accessed 2022)
455,526 (368,948 - 551,037) 2019 Modelled IHME, GBD 2019 (accessed 2022)
448,841 (362,710 - 544,260) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
26,800 (14,000 - 43,100) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

National
Download
Value Year Type Source
1,382 2019 Survey/reported European Centre for Disease Prevention and Control, 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
10.5 (8.76 - 12.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
9.95 (8.11 - 12.19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10.04 (8.21 - 12.21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
10.01 (8.23 - 12.22) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10.03 (8.27 - 12.16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10.09 (8.35 - 12.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10.22 (8.42 - 12.28) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10.34 (8.52 - 12.43) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.29 (8.57 - 12.35) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.41 (8.66 - 12.44) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.52 (8.74 - 12.57) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.39 (8.60 - 12.40) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.4 (8.62 - 12.38) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.5 (8.73 - 12.50) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10.59 (8.80 - 12.60) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10.48 (8.73 - 12.42) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10.13 (8.39 - 11.98) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10.34 (8.62 - 12.25) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10.07 (8.35 - 11.85) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9.96 (8.30 - 11.70) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9.78 (8.16 - 11.46) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9.87 (8.23 - 11.58) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9.89 (8.27 - 11.57) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9.83 (8.21 - 11.52) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9.9 (8.28 - 11.58) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10.18 (8.49 - 11.94) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9.97 (8.34 - 11.67) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10.19 (8.51 - 11.96) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10.27 (8.50 - 12.11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10.36 (8.63 - 12.15) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10.47 (8.76 - 12.25) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5.9 2019 Survey/reported Politi et al J, 2021
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,316 2016 Modelled WHO
4,817 (4,031 - 5,637) 2019 Modelled IHME, GBD 2019 (accessed 2022)
4,817 (4,031 - 5,638) 2019 Modelled IHME, GBD 2019 (accessed 2020)
4,785 (3,988 - 5,614) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4,762 (3,942 - 5,616) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4,743 (3,961 - 5,569) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4,755 (3,966 - 5,580) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4,679 (3,914 - 5,476) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4,653 (3,894 - 5,447) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4,671 (3,905 - 5,460) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4,637 (3,872 - 5,434) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4,594 (3,834 - 5,385) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4,601 (3,840 - 5,400) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4,595 (3,827 - 5,399) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4,583 (3,798 - 5,393) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4,543 (3,764 - 5,370) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4,565 (3,804 - 5,407) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4,553 (3,790 - 5,396) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4,523 (3,762 - 5,383) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,412 (3,671 - 5,253) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,303 (3,565 - 5,123) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4,240 (3,509 - 5,062) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,247 (3,528 - 5,074) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,162 (3,465 - 4,977) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,089 (3,403 - 4,905) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,085 (3,366 - 4,908) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,017 (3,312 - 4,830) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3,954 (3,273 - 4,759) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3,920 (3,231 - 4,750) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3,902 (3,208 - 4,760) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3,901 (3,190 - 4,744) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,858 (3,145 - 4,726) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
34 (27 - 41) 1990 Modelled IHME, GBD 2019 (accessed 2022)
35 (28 - 43) 1991 Modelled IHME, GBD 2019 (accessed 2022)
38 (30 - 46) 1992 Modelled IHME, GBD 2019 (accessed 2022)
42 (33 - 51) 1994 Modelled IHME, GBD 2019 (accessed 2022)
40 (31 - 48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
44 (34 - 53) 1995 Modelled IHME, GBD 2019 (accessed 2022)
46 (36 - 56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
48 (38 - 59) 1997 Modelled IHME, GBD 2019 (accessed 2022)
50 (39 - 60) 1998 Modelled IHME, GBD 2019 (accessed 2022)
52 (41 - 63) 1999 Modelled IHME, GBD 2019 (accessed 2022)
54 (43 - 66) 2000 Modelled IHME, GBD 2019 (accessed 2022)
56 (44 - 67) 2001 Modelled IHME, GBD 2019 (accessed 2022)
57 (45 - 69) 2002 Modelled IHME, GBD 2019 (accessed 2022)
57 (45 - 69) 2003 Modelled IHME, GBD 2019 (accessed 2022)
58 (46 - 70) 2004 Modelled IHME, GBD 2019 (accessed 2022)
58 (46 - 70) 2005 Modelled IHME, GBD 2019 (accessed 2022)
59 (47 - 71) 2006 Modelled IHME, GBD 2019 (accessed 2022)
60 (48 - 71) 2007 Modelled IHME, GBD 2019 (accessed 2022)
61 (49 - 72) 2008 Modelled IHME, GBD 2019 (accessed 2022)
63 (50 - 74) 2009 Modelled IHME, GBD 2019 (accessed 2022)
64 (52 - 76) 2010 Modelled IHME, GBD 2019 (accessed 2022)
67 (54 - 80) 2013 Modelled IHME, GBD 2019 (accessed 2022)
65 (53 - 77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
66 (53 - 78) 2012 Modelled IHME, GBD 2019 (accessed 2022)
67 (54 - 80) 2014 Modelled IHME, GBD 2019 (accessed 2022)
66 (53 - 79) 2015 Modelled IHME, GBD 2019 (accessed 2022)
66 (53 - 80) 2016 Modelled IHME, GBD 2019 (accessed 2022)
65 (53 - 79) 2017 Modelled IHME, GBD 2019 (accessed 2022)
64 (52 - 77) 2018 Modelled IHME, GBD 2019 (accessed 2022)
64 (51 - 77) 2019 Modelled IHME, GBD 2019 (accessed 2022)
55 (45 - 65) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
29,151 2017 Survey/reported ECDC, 2019
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
119 2016 Survey/reported EMCDDA, 2019
141 (84 - 428) 2015 Survey/reported EMCDDA, 2017
Showing out of
Show more
Technical notes

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
71 2016 Survey/reported Ministerio de Sanidad, Servicios Sociales e Igualidad, 2020
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Overview

Resources